Author

Walter John Urba

ORCID 0000-0001-8414-3348Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Brian PieningiD· 2 shared Alexa K. DowdelliD· 1 shared Ann VitaiD· 1 shared Bela Bapat· 1 shared Brady M. BernardiD· 1 shared Brock Schroeder· 1 shared Carlo Bruno BifulcoiD· 1 shared Cliff WongiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Brian PieningORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintDec 5, 2025

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of soft tissue sarcoma

Jianguo Huang, Xingliang Liu, Warren Floyd…·David G. Kirsch

The paper identifies BAP1 as a tumor suppressor in soft tissue sarcoma using an in vivo CRISPR screen and shows that PLK1 inhibition can suppress tumor growth in BAP1-deficient models.

DOI 10.64898/2025.12.01.691734

mousebulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineJCO Oncology PracticePeer-reviewedNov 1, 2024

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health system

Alexa K. Dowdell, Ryan Meng, Ann Vita…·Brian Piening

This study shows that precision therapies have become more common than traditional chemotherapy in advanced cancer patients after implementing comprehensive genomic profiling.

13 citations

humanwhole-exome sequencing

𝕏 PostBluesky